Brief: Century Therapeutics Q3 Net Income USD -31.226 Million
05/11/2024 14:05
Nov 05 (Reuters) - Century Therapeutics Q3 operating expenses USD 35.58 million. * Q3 operating income USD -34.789 million * Q3 basic EPS USD -0.37 * outlook FY operating expenses USD 150-160 million
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview